US 11001551
Controlled release pharmaceutical formulations
granted A61KA61K31/5575A61K31/558
Quick answer
US patent 11001551 (Controlled release pharmaceutical formulations) held by United Therapeutics Corporation expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/5575, A61K31/558, A61P, A61P11/00